-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On June 25, Shanghai Pharmaceuticals announced that Xinyi Wanxiang, a subsidiary of the company, received the "Drug Supplementary Application Approval Notice" issued by the State Drug Administration for metronidazole tablets.
Metronidazole tablets are mainly used to treat and prevent infections identified or suspected to be caused by anaerobic bacteria; it has inhibitory activity against a variety of pathogenic microorganisms, especially Bacteroides, Fusobacterium, Clostridium, Eubacteria, Peptococcus, Peptostreptococcus, anaerobic cocci and Gardnerella vaginalis; also treats Trichomonas, Entamoeba histolytica, Giardia, Colonic ciliates and Dracunculiasis Role